US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Impact Biomedical, Inc.

0.4717

-0.0145-2.98%

Post-market: 0.50590.0342+7.25%19:58 EST

Volume:49.64K

Turnover:23.92K

Market Cap:49.53M

PE:-0.13

High:0.5005

Open:0.4601

Low:0.4590

Close:0.4862

52wk High:6.17

52wk Low:0.3621

Shares:105.00M

Float Shares:11.64M

Volume Ratio:0.61

T/O Rate:0.43%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.6869

EPS(LYR):-2.2969

ROE:-346.99%

ROA:-7.68%

PB:-4.17

PE(LYR):-0.21

Loading ...

Overview Company News Filings

Universal Ibogaine Ties Delayed Audit to Restructuring and Planned Sale of Kelburn Facility

DSS, Inc. Reports Disposal of Impact Biomedical Inc. Common Shares

Impact Biomedical Inc. Files Information Statement Outlining Authorized Corporate Actions

Impact Biomedical Inc. Files Preliminary Information Statement Outlining Authorized Corporate Actions

Universal Ibogaine Seeks Cease Trade Order Amid Financial Filing Delays

Impact Biomedical Inc. held annual shareholder meeting

Impact BioMedical Converts Preferred Stock to Common

Universal Ibogaine Restructures Board Ahead of Clinical Trial Submission

Impact Biomedical Inc. Announces Date for 2025 Annual Stockholders Meeting

Universal Ibogaine Announces Key Outcomes from Annual Shareholder Meeting

Impact BioMedical Inc. Approves Issuance of 31.9 Million Shares to DSS, Inc

Impact BioMedical Inc. Approves Issuance of 31.9 Million Shares to DSS, Inc

Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue

Impact BioMedical Q2 EPS $(1.18), Sales $7.00K

Impact BioMedical Inc. Approves 2023 Equity Incentive Plan and Reserves 5 Million Common Stock Shares

DSS Inc. Announces Debt Conversion Agreement with Impact Biomedical, Settling $12M Debt for Common Shares

Impact Biomedical Inc - to Issue 31,939,778 Shares to Settle Debt - SEC Filing

THOMSON REUTERS

Impact Biomedical Inc - on July 21, Enters Debt Conversion Agreement With Dss - SEC Filing

THOMSON REUTERS

Impact BioMedical Inc. Announces Debt Conversion Agreement to Settle $12 Million Loan with DSS, Inc. Through Issuance of Common Stock

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IBO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBO\",,,,,undefined,":{"symbol":"IBO","market":"US","secType":"STK","nameCN":"Impact Biomedical, Inc.","latestPrice":0.4717,"timestamp":1770411600000,"preClose":0.4862,"halted":0,"volume":49636,"hourTrading":{"tag":"盘后","latestPrice":0.5059,"preClose":0.4717,"latestTime":"19:58 EST","volume":432,"amount":218.3493,"timestamp":1770425916198,"change":0.0342,"changeRate":0.072504,"amplitude":0.072716},"delay":0,"changeRate":-0.0298231180584122,"floatShares":11638100,"shares":105000000,"eps":-3.686859,"marketStatus":"Market Closed","change":-0.0145,"latestTime":"02-06 16:00:00 EST","open":0.4601,"high":0.5005,"low":0.459,"amount":23924.65822104,"amplitude":0.085356,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.686859,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1721361600000,"exchange":"AMEX","adjPreClose":0.4862,"preHourTrading":{"tag":"盘前","latestPrice":0.4861,"preClose":0.4862,"latestTime":"08:00 EST","volume":18,"amount":8.7498,"timestamp":1770382802410,"change":-0.0001,"changeRate":-0.000206,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":0.5059,"preClose":0.4717,"latestTime":"19:58 EST","volume":432,"amount":218.3493,"timestamp":1770425916198,"change":0.0342,"changeRate":0.072504,"amplitude":0.072716},"volumeRatio":0.6112284963820014,"impliedVol":0.2695,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBO\",,,,,undefined,":{"symbol":"IBO","floatShares":11638100,"roa":"-7.68%","roe":"-346.99%","lyrEps":-2.296891,"volumeRatio":0.6112284963820014,"shares":105000000,"dividePrice":0,"high":0.5005,"amplitude":0.085356,"preClose":0.4862,"low":0.459,"week52Low":0.3621,"pbRate":"-4.17","psRate":"1981.14","week52High":6.17,"institutionHeld":0,"latestPrice":0.4717,"eps":-3.686859,"divideRate":0,"volume":49636,"delay":0,"ttmEps":-3.686859,"open":0.4601,"prevYearClose":0.505,"prevWeekClose":0.49,"prevMonthClose":0.49,"prevQuarterClose":0.505,"fiveDayClose":0.49,"twentyDayClose":0.506,"sixtyDayClose":0.5596},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBO\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IBO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IBO","date":"2026-02-06","current":-0.127941,"percent":0.195965,"low":-7.852882,"twenty":-1.149458,"median":-0.23584,"eighty":14.989702,"high":48.978211,"avg":3.986069,"sd":9.705003,"marketCap":50866842},"quantilePoints":[{"date":"2024-09-20","current":-6.823884,"twenty":-6.997189,"median":-6.647871,"eighty":-6.406869,"marketCap":28974211},{"date":"2024-09-27","current":-6.471858,"twenty":-6.910536,"median":-6.471858,"eighty":-6.309385,"marketCap":27479510},{"date":"2024-10-04","current":-4.468019,"twenty":-6.775142,"median":-6.309385,"eighty":-5.239768,"marketCap":18971209},{"date":"2024-10-11","current":-4.260324,"twenty":-6.580174,"median":-5.415781,"eighty":-4.180929,"marketCap":18089336},{"date":"2024-10-18","current":-3.864701,"twenty":-6.471858,"median":-5.077294,"eighty":-4.002262,"marketCap":16409521},{"date":"2024-10-25","current":-4.738808,"twenty":-6.374374,"median":-4.468019,"eighty":-3.910194,"marketCap":20120980},{"date":"2024-10-31","current":-5.984438,"twenty":-6.309385,"median":-5.036676,"eighty":-3.937273,"marketCap":25409923},{"date":"2024-11-08","current":-7.552848,"twenty":-6.791389,"median":-5.368393,"eighty":-3.986015,"marketCap":32069393},{"date":"2024-11-15","current":24.785345,"twenty":-7.039432,"median":-5.415781,"eighty":-3.937273,"marketCap":28874927},{"date":"2024-11-22","current":25.871555,"twenty":-6.952238,"median":-5.077294,"eighty":-3.531089,"marketCap":30140362},{"date":"2024-11-29","current":28.833947,"twenty":-6.807637,"median":-4.603414,"eighty":19.151303,"marketCap":33591548},{"date":"2024-12-06","current":22.514178,"twenty":-6.688489,"median":-4.260324,"eighty":24.785345,"marketCap":26229017},{"date":"2024-12-13","current":21.230475,"twenty":-6.471858,"median":-4.053712,"eighty":24.548354,"marketCap":24733503},{"date":"2024-12-20","current":16.490647,"twenty":-6.439363,"median":-3.95352,"eighty":23.560889,"marketCap":19211604},{"date":"2024-12-27","current":15.799423,"twenty":-6.309385,"median":-3.885823,"eighty":23.402895,"marketCap":18406328},{"date":"2025-01-03","current":15.206944,"twenty":-6.309385,"median":-3.628573,"eighty":23.007909,"marketCap":17716090},{"date":"2025-01-10","current":17.774351,"twenty":-6.27689,"median":-3.439292,"eighty":22.790667,"marketCap":20707119},{"date":"2025-01-17","current":15.898169,"twenty":-6.092754,"median":12.787657,"eighty":22.593175,"marketCap":18521367},{"date":"2025-01-24","current":15.503184,"twenty":-5.93028,"median":14.167144,"eighty":22.435181,"marketCap":18061209},{"date":"2025-01-31","current":18.308568,"twenty":-5.773222,"median":14.515719,"eighty":22.000696,"marketCap":21329482},{"date":"2025-02-07","current":18.663068,"twenty":-5.562007,"median":14.960078,"eighty":21.408218,"marketCap":21742474},{"date":"2025-02-14","current":21.230475,"twenty":-5.415781,"median":15.40345,"eighty":21.8822,"marketCap":24733503},{"date":"2025-02-21","current":19.749279,"twenty":-5.396826,"median":15.503184,"eighty":21.526713,"marketCap":23007910},{"date":"2025-02-28","current":15.206944,"twenty":-5.280387,"median":15.799423,"eighty":21.467465,"marketCap":17716090},{"date":"2025-03-07","current":11.948313,"twenty":-5.101666,"median":15.503184,"eighty":21.230475,"marketCap":13919785},{"date":"2025-03-14","current":6.617983,"twenty":-4.977102,"median":15.305197,"eighty":21.210726,"marketCap":7709950},{"date":"2025-03-21","current":20.53925,"twenty":-4.68465,"median":15.206944,"eighty":21.092229,"marketCap":23928226},{"date":"2025-03-28","current":22.514178,"twenty":-4.44094,"median":15.403944,"eighty":21.526713,"marketCap":26229017},{"date":"2025-04-04","current":-0.226956,"twenty":-4.318165,"median":15.206944,"eighty":21.467465,"marketCap":5607631},{"date":"2025-04-11","current":-0.249456,"twenty":-4.247705,"median":14.713213,"eighty":21.230475,"marketCap":6163560},{"date":"2025-04-17","current":-0.21375,"twenty":-4.19723,"median":14.416973,"eighty":21.230475,"marketCap":5281325},{"date":"2025-04-25","current":-0.20788,"twenty":-4.061836,"median":14.219481,"eighty":21.131728,"marketCap":5136300},{"date":"2025-05-02","current":-0.195652,"twenty":-4.045588,"median":14.120734,"eighty":20.934235,"marketCap":4834164},{"date":"2025-05-09","current":-0.243342,"twenty":-4.034757,"median":11.653062,"eighty":20.934235,"marketCap":6012492},{"date":"2025-05-16","current":-0.248299,"twenty":-3.95352,"median":8.822497,"eighty":20.931273,"marketCap":6210693},{"date":"2025-05-23","current":-0.265741,"twenty":-3.926441,"median":6.617983,"eighty":20.53925,"marketCap":6646976},{"date":"2025-05-30","current":-0.236751,"twenty":-3.893947,"median":6.024517,"eighty":20.53925,"marketCap":5921851},{"date":"2025-06-06","current":-0.240616,"twenty":-3.868925,"median":5.431051,"eighty":20.065268,"marketCap":6018535},{"date":"2025-06-13","current":-0.228296,"twenty":-3.675799,"median":-0.196924,"eighty":19.788778,"marketCap":5710357},{"date":"2025-06-20","current":-0.208921,"twenty":-3.531089,"median":-0.205288,"eighty":19.749279,"marketCap":5225732},{"date":"2025-06-27","current":-0.444512,"twenty":-3.450015,"median":-0.207718,"eighty":19.630783,"marketCap":11118579},{"date":"2025-07-03","current":-0.315507,"twenty":-3.41752,"median":-0.208564,"eighty":19.492537,"marketCap":7891774},{"date":"2025-07-11","current":-0.276757,"twenty":-2.342076,"median":-0.2115,"eighty":19.265421,"marketCap":6922523},{"date":"2025-07-18","current":-0.337104,"twenty":-0.74982,"median":-0.215206,"eighty":19.038305,"marketCap":8431991},{"date":"2025-07-25","current":-0.333674,"twenty":-0.612978,"median":-0.222159,"eighty":18.909935,"marketCap":8346185},{"date":"2025-08-01","current":-0.294972,"twenty":-0.468414,"median":-0.227287,"eighty":18.761815,"marketCap":7378144},{"date":"2025-08-08","current":-0.284053,"twenty":-0.45663,"median":-0.231823,"eighty":18.722316,"marketCap":7105013},{"date":"2025-08-15","current":-0.273955,"twenty":-0.436592,"median":-0.234874,"eighty":18.663068,"marketCap":6852428},{"date":"2025-08-22","current":-0.188262,"twenty":-0.41717,"median":-0.231823,"eighty":18.521268,"marketCap":7243008},{"date":"2025-08-29","current":-0.18606,"twenty":-0.405543,"median":-0.227287,"eighty":18.292374,"marketCap":7158283},{"date":"2025-09-05","current":-0.184588,"twenty":-0.400413,"median":-0.223319,"eighty":18.268082,"marketCap":7101658},{"date":"2025-09-12","current":-0.207551,"twenty":-0.378605,"median":-0.215733,"eighty":18.169336,"marketCap":7985100},{"date":"2025-09-19","current":-0.208501,"twenty":-0.365363,"median":-0.215554,"eighty":17.754602,"marketCap":8021656},{"date":"2025-09-26","current":-0.205207,"twenty":-0.359697,"median":-0.214679,"eighty":17.655855,"marketCap":7894928},{"date":"2025-10-03","current":-0.204162,"twenty":-0.344709,"median":-0.211774,"eighty":17.555134,"marketCap":7854716},{"date":"2025-10-10","current":-0.197922,"twenty":-0.342409,"median":-0.21056,"eighty":17.430516,"marketCap":7614663},{"date":"2025-10-17","current":-0.190511,"twenty":-0.339607,"median":-0.20889,"eighty":17.24033,"marketCap":7329525},{"date":"2025-10-24","current":-0.184968,"twenty":-0.338302,"median":-0.208343,"eighty":17.023878,"marketCap":7116280},{"date":"2025-10-31","current":-0.166598,"twenty":-0.336418,"median":-0.208076,"eighty":16.727639,"marketCap":6409526},{"date":"2025-11-07","current":-0.169068,"twenty":-0.333268,"median":-0.207551,"eighty":16.464578,"marketCap":6504572},{"date":"2025-11-14","current":-1.207414,"twenty":-0.342409,"median":-0.208076,"eighty":16.307374,"marketCap":53356827},{"date":"2025-11-21","current":-1.065365,"twenty":-0.378605,"median":-0.208343,"eighty":16.056163,"marketCap":47079553},{"date":"2025-11-28","current":-1.055895,"twenty":-0.424711,"median":-0.208858,"eighty":15.898169,"marketCap":46661069},{"date":"2025-12-05","current":-1.112715,"twenty":-0.707706,"median":-0.20991,"eighty":15.799423,"marketCap":49171978},{"date":"2025-12-12","current":-1.155566,"twenty":-1.035061,"median":-0.2115,"eighty":15.799423,"marketCap":51065622},{"date":"2025-12-19","current":-1.050687,"twenty":-1.044295,"median":-0.214215,"eighty":15.60193,"marketCap":46430902},{"date":"2025-12-26","current":-1.207651,"twenty":-1.055895,"median":-0.215041,"eighty":15.522933,"marketCap":53367289},{"date":"2026-01-02","current":-1.195576,"twenty":-1.0701,"median":-0.215838,"eighty":15.443936,"marketCap":52833721},{"date":"2026-01-09","current":-1.197944,"twenty":-1.090697,"median":-0.222159,"eighty":15.403845,"marketCap":52938342},{"date":"2026-01-16","current":-1.124315,"twenty":-1.139041,"median":-0.225853,"eighty":15.285546,"marketCap":49684622},{"date":"2026-01-23","current":-1.133904,"twenty":-1.140367,"median":-0.227957,"eighty":15.206944,"marketCap":50108338},{"date":"2026-01-30","current":-1.12692,"twenty":-1.135396,"median":-0.231919,"eighty":15.167446,"marketCap":49799705},{"date":"2026-02-06","current":-1.151068,"twenty":-1.149458,"median":-0.23584,"eighty":14.989702,"marketCap":50866842}],"updateTime":1770533462110},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2604349901","title":"Universal Ibogaine Ties Delayed Audit to Restructuring and Planned Sale of Kelburn Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2604349901","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604349901?lang=en_us&edition=fundamental","pubTime":"2026-01-19 23:03","pubTimestamp":1768835016,"startTime":"0","endTime":"0","summary":"Universal Ibogaine Inc ( ($TSE:IBO) ) has provided an announcement. Universal Ibogaine Inc. has provided an update on its delayed year-end 2025 fin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-ties-delayed-audit-to-restructuring-and-planned-sale-of-kelburn-facility?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-ties-delayed-audit-to-restructuring-and-planned-sale-of-kelburn-facility?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBO","BK4075","BK4007","UVV"],"gpt_icon":0},{"id":"2601846897","title":"DSS, Inc. Reports Disposal of Impact Biomedical Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2601846897","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601846897?lang=en_us&edition=fundamental","pubTime":"2026-01-07 06:25","pubTimestamp":1767738346,"startTime":"0","endTime":"0","summary":"DSS, Inc., a significant beneficial owner, reported the disposal of common shares of Impact Biomedical Inc. . The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL2K7n2x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4087","IBO","DSS","AEI","BK4563","BK4024"],"gpt_icon":0},{"id":"2595710329","title":"Impact Biomedical Inc. Files Information Statement Outlining Authorized Corporate Actions","url":"https://stock-news.laohu8.com/highlight/detail?id=2595710329","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595710329?lang=en_us&edition=fundamental","pubTime":"2025-12-31 05:31","pubTimestamp":1767130277,"startTime":"0","endTime":"0","summary":"Impact BioMedical Inc. has announced that its shareholders have authorized key corporate actions as of December 30, 2025. These actions include amendments to the company’s Certificate of Incorporation and a reverse stock split, as referenced in recent company filings. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 30, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDLNc4vD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","IBO","AEI","BK4007","BK4024"],"gpt_icon":0},{"id":"2590544147","title":"Impact Biomedical Inc. Files Preliminary Information Statement Outlining Authorized Corporate Actions","url":"https://stock-news.laohu8.com/highlight/detail?id=2590544147","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590544147?lang=en_us&edition=fundamental","pubTime":"2025-12-12 06:12","pubTimestamp":1765491147,"startTime":"0","endTime":"0","summary":"Impact BioMedical Inc. shareholders have authorized key corporate actions, including a Reverse Stock Split and changes to Authorized Shares. These actions were approved on March 28, 2025. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 11, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL4jW1CS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4024","BK4007","AEI","IBO"],"gpt_icon":0},{"id":"2586340411","title":"Universal Ibogaine Seeks Cease Trade Order Amid Financial Filing Delays","url":"https://stock-news.laohu8.com/highlight/detail?id=2586340411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586340411?lang=en_us&edition=fundamental","pubTime":"2025-11-26 06:05","pubTimestamp":1764108331,"startTime":"0","endTime":"0","summary":"Universal Ibogaine Inc ( ($TSE:IBO) ) has issued an announcement. Universal Ibogaine Inc. has applied for a management cease trade order (MCTO) due...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-seeks-cease-trade-order-amid-financial-filing-delays?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-seeks-cease-trade-order-amid-financial-filing-delays?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBO","UVV","BK4007","BK4075"],"gpt_icon":0},{"id":"2581048866","title":"Impact Biomedical Inc. held annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2581048866","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581048866?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:15","pubTimestamp":1762463715,"startTime":"0","endTime":"0","summary":"Impact Biomedical Inc. held its annual meeting of stockholders on November 5, 2025. During the meeting, stockholders approved the election of Frank D. Heuszel, Elise Brownell, Melissa Sims, Castel Hibbert, David Keene, Christian Zimmerman, Jason Grady, and Chan Heng Fai Ambrose to the board of directors. The appointment of Grassi & Co. Certified Public Accountants, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was also ratified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL3l9MFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4024","BK4563","AEI","IBO","BK4007"],"gpt_icon":0},{"id":"2578072675","title":"Impact BioMedical Converts Preferred Stock to Common","url":"https://stock-news.laohu8.com/highlight/detail?id=2578072675","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578072675?lang=en_us&edition=fundamental","pubTime":"2025-10-28 04:35","pubTimestamp":1761597320,"startTime":"0","endTime":"0","summary":"Impact BioMedical, Inc. ( ($IBO) ) has shared an update. On October 30, 2023, Impact BioMedical, Inc. announced that DSS BioHealth Security, Inc. h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/impact-biomedical-converts-preferred-stock-to-common?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/impact-biomedical-converts-preferred-stock-to-common?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","IBO"],"gpt_icon":0},{"id":"2569741867","title":"Universal Ibogaine Restructures Board Ahead of Clinical Trial Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2569741867","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569741867?lang=en_us&edition=fundamental","pubTime":"2025-09-24 05:42","pubTimestamp":1758663760,"startTime":"0","endTime":"0","summary":"Universal Ibogaine Inc ( ($TSE:IBO) ) has issued an announcement. Universal Ibogaine Inc. announced changes to its Board of Directors, with several...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-restructures-board-ahead-of-clinical-trial-submission?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-restructures-board-ahead-of-clinical-trial-submission?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UVV","IBO","BK4075","BK4007"],"gpt_icon":0},{"id":"2569712650","title":"Impact Biomedical Inc. Announces Date for 2025 Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2569712650","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569712650?lang=en_us&edition=fundamental","pubTime":"2025-09-24 00:39","pubTimestamp":1758645556,"startTime":"0","endTime":"0","summary":"Impact BioMedical Inc. is set to hold its Annual Meeting of Stockholders on November 5, 2025, at their Houston location. The meeting will cover key resolutions, including the election of eight director nominees to serve until the next annual meeting, the ratification of Grassi & Co. Certified Public Accountants, P.C. as the Company's independent registered public accounting firm for the year ending December 31, 2025, and an advisory vote to approve executive compensation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDL5jrcsS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4024","BK4563","IBO","BK4007","AEI"],"gpt_icon":0},{"id":"2567519868","title":"Universal Ibogaine Announces Key Outcomes from Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2567519868","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567519868?lang=en_us&edition=fundamental","pubTime":"2025-09-15 13:08","pubTimestamp":1757912901,"startTime":"0","endTime":"0","summary":"An update from Universal Ibogaine Inc ( ($TSE:IBO) ) is now available. Universal Ibogaine Inc. held its annual meeting of shareholders, where nine ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-announces-key-outcomes-from-annual-shareholder-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-announces-key-outcomes-from-annual-shareholder-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UVV","BK4075","BK4007","IBO"],"gpt_icon":0},{"id":"2566186645","title":"Impact BioMedical Inc. Approves Issuance of 31.9 Million Shares to DSS, Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2566186645","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566186645?lang=en_us&edition=fundamental","pubTime":"2025-09-10 05:04","pubTimestamp":1757451852,"startTime":"0","endTime":"0","summary":"Impact BioMedical Inc., a Nevada-based corporation, has announced that its Board of Directors and shareholders holding a majority of the company's outstanding voting capital stock have approved certain actions. The details of these decisions, which were taken on July 14, 2025, will become effective on a future date. Impact BioMedical Inc. is headquartered in Houston, Texas. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 09, 2025, and is solely responsibl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nNDL5kMgM9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4087","DSS","BK4563","BK4024","IBO","BK4007","AEI"],"gpt_icon":0},{"id":"2562773111","title":"Impact BioMedical Inc. Approves Issuance of 31.9 Million Shares to DSS, Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2562773111","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562773111?lang=en_us&edition=fundamental","pubTime":"2025-08-26 21:15","pubTimestamp":1756214146,"startTime":"0","endTime":"0","summary":"Impact BioMedical Inc., a Nevada-based corporation, announced that its Board of Directors and majority stockholders have approved certain key actions. These decisions were finalized on July 14, 2025, and will be implemented following a designated period. The company, headquartered in Houston, Texas, continues to focus on advancing its strategic objectives and fostering growth in the biomedical sector.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 25, 2025, and is solely responsible for the information contained","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nNDL6D11np:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBO","AEI","BK4563","BK4087","BK4007","BK4024","DSS"],"gpt_icon":0},{"id":"2560188843","title":"Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2560188843","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560188843?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:30","pubTimestamp":1755520200,"startTime":"0","endTime":"0","summary":"HOUSTON, Aug.  18, 2025  (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBO) is pleased to announce that the US Patent and Trademark Office has issued U.S. patent No. 12,357,584 B2 entitled “Composition ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/18/3135021/0/en/Impact-Biomedical-Inc-IBO-Announces-3F-US-Patent-Issue.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBO","BK4568","BK4139","BK4007","IBIO"],"gpt_icon":0},{"id":"2559676509","title":"Impact BioMedical Q2 EPS $(1.18), Sales $7.00K","url":"https://stock-news.laohu8.com/highlight/detail?id=2559676509","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559676509?lang=en_us&edition=fundamental","pubTime":"2025-08-15 05:48","pubTimestamp":1755208108,"startTime":"0","endTime":"0","summary":"Impact BioMedical (AMEX:IBO) reported quarterly losses of $(1.18) per share.  The company reported $7.00 thousand in sales this quarter.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47142971/impact-biomedical-q2-eps-1-18-sales-7-00k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Impact BioMedical Q2 EPS $(1.18), Sales $7.00K","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBO"],"gpt_icon":0},{"id":"2557314673","title":"Impact BioMedical Inc. Approves 2023 Equity Incentive Plan and Reserves 5 Million Common Stock Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2557314673","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557314673?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:34","pubTimestamp":1754426049,"startTime":"0","endTime":"0","summary":"Impact BioMedical Inc., a Nevada corporation based in Houston, Texas, announced that its board of directors and shareholders holding a majority of the company's outstanding voting capital stock have approved certain corporate actions. These resolutions were formalized on August 5, 2025, and are expected to be implemented in the near future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 05, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDL6ySXZm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4024","BK4007","AEI","BK4563","IBO"],"gpt_icon":0},{"id":"2555202446","title":"DSS Inc. Announces Debt Conversion Agreement with Impact Biomedical, Settling $12M Debt for Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2555202446","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555202446?lang=en_us&edition=fundamental","pubTime":"2025-07-31 04:14","pubTimestamp":1753906453,"startTime":"0","endTime":"0","summary":"On July 21, 2025, DSS, Inc. announced the successful execution of a Debt Conversion Agreement with Impact Biomedical Inc. This agreement involves the conversion of all outstanding debt owed by Impact, originally amounting to $12 million under a revolving promissory note, into 31,939,778 shares of Impact's common stock. This strategic move effectively settles the debt, including any additional financial or operational support extended by DSS or its affiliates, marking a significant step in DSS's financial strategy. The shares, valued at $0.001 per share, now constitute full and final satisfaction of all amounts owed, showcasing DSS's commitment to innovative financial solutions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dss Inc. pu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250730:nNDL3bBlZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4087","AEI","DSS","BK4563","BK4007","BK4024","IBO"],"gpt_icon":0},{"id":"2554794770","title":"Impact Biomedical Inc - to Issue 31,939,778 Shares to Settle Debt - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2554794770","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554794770?lang=en_us&edition=fundamental","pubTime":"2025-07-28 23:12","pubTimestamp":1753715576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nFWN3TP1FU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBO","BK4007"],"gpt_icon":0},{"id":"2554277079","title":"Impact Biomedical Inc - on July 21, Enters Debt Conversion Agreement With Dss - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2554277079","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554277079?lang=en_us&edition=fundamental","pubTime":"2025-07-28 23:12","pubTimestamp":1753715576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nFWN3TP1FU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBO","BK4007"],"gpt_icon":0},{"id":"2554702687","title":"Impact BioMedical Inc. Announces Debt Conversion Agreement to Settle $12 Million Loan with DSS, Inc. Through Issuance of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2554702687","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554702687?lang=en_us&edition=fundamental","pubTime":"2025-07-28 23:06","pubTimestamp":1753715168,"startTime":"0","endTime":"0","summary":"Impact BioMedical Inc. Announces Debt Conversion Agreement to Settle $12 Million Loan with DSS, Inc. Through Issuance of Common Stock. Impact BioMedical Inc. has announced a significant financial restructuring through a Debt Conversion Agreement with DSS, Inc. The agreement involves the conversion of an outstanding loan, originally valued at $12 million, into common stock. Under the terms of the agreement, Impact BioMedical will issue 31,939,778 shares of its common stock to DSS, effectively settling the debt in full. The original loan, which was subject to amendments including a revised interest rate of WSJ Prime + 0.5%, will be entirely satisfied with this conversion. This strategic move aims to strengthen Impact BioMedical's financial position by reducing its debt obligations.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nNDLlyJpC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEI","DSS","IBO","BK4087","BK4563","BK4024","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}